OrthoPediatrics closes $25M term loan and $50M convertible notes issuance

ORTHOPEDIATRICS CORP

$25M term loan from Braidwell LP funded on August 12, 2024.
Issued $50M aggregate principal of 4.75% Convertible Senior Notes due Feb 15, 2030 to Braidwell.
Initial conversion rate of 33.8294 shares per $1,000 principal, maximum 1,691,470 shares issuable.
Notes issued under Section 4(a)(2) in a private placement; resale restricted to QIBs for 12 months.
Transactions were previously announced on August 5, 2024; closing occurred on August 12, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.